VANCOUVER, British Columbia--(BUSINESS WIRE)--May 5, 2006--MIV Therapeutics (OTCBB:MIVT - News; FWB:MIV), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, today announced the establishment of an official U.S. headquarters with the opening of a new corporate office in Atlanta, GA.
